论文部分内容阅读
通过55例的临床分析,提示高热与腹泻以死亡组为多而重,压痛与反跳痛则以存活组为明显而典型。腹水培养阳性率以死亡组为高,以大肠杆菌为主。总结了预后与并发症及死亡原因的关系,死亡率占67.27％,存活率占25.45％,在76例次治疗中治愈32例次,占42.11％。探讨了疗效与药敏、给药方式及疗程间的关系。认为联合治疗优于单一治疗,疗程以≤2周为宜。强调早期诊断、合理治疗及有效的预防措施是决定预后及提高存活率的重要环节。
Through 55 cases of clinical analysis, suggesting that high fever and diarrhea in the death group was more and more weight, tenderness and rebound pain in the survival group was obvious and typical. The positive rate of ascites culture was higher in death group than in Escherichia coli. The relationship between prognosis and complication and the cause of death was summarized. The mortality rate was 67.27% and the survival rate was 25.45%. Among 76 cases, 32 cases were cured, accounting for 42.11%. Explore the efficacy and susceptibility, administration and the relationship between the course of treatment. That the combination therapy is better than a single treatment, treatment is less than 2 weeks is appropriate. Emphasis on early diagnosis, reasonable treatment and effective preventive measures is to determine the prognosis and improve the survival rate of an important part.